Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Post‑Viral Upper Airway Cough Syndrome (UACS) with Secondary Acute Bacterial Rhinosinusitis

Diagnostic Indicators

  • A 2‑week course of watery rhinorrhea that progresses to purulent nasal discharge and a productive cough strongly suggests bacterial superinfection after an initial viral URI. 1
  • Frontal headache that worsens in the morning is characteristic of sinusitis caused by overnight mucus stasis and sinus pressure. 1
  • The appearance of whitish‑yellow sputum indicates bacterial involvement of the upper airway secretions. 1
  • Persistence of symptoms beyond 10 days without improvement (viral rhinitis usually resolves within 7–10 days) points toward acute bacterial rhinosinusitis; this occurs in < 2 % of viral cases. 1
  • Lack of allergic features (no itching, sneezing, seasonal pattern) and the shift from clear to purulent discharge help exclude allergic rhinitis. 2

First‑Line Pharmacologic Management for UACS

Intervention Typical Regimen Rationale / Evidence
First‑generation antihistamine + decongestant (e.g., dexbrompheniramine 6 mg + pseudoephedrine 120 mg SR, BID) Oral, twice daily Controlled studies demonstrate efficacy for post‑viral UACS; anticholinergic effect reduces non‑histamine‑mediated rhinitis. Improvement expected within days to 2 weeks. [3]
Ipratropium bromide nasal spray (alternative) Intranasal, as directed Provides anticholinergic nasal decongestion when first‑generation antihistamines are contraindicated (e.g., glaucoma, BPH). [3]
Avoid newer‑generation antihistamines (e.g., loratadine, terfenadine) — Lack anticholinergic activity and have been shown ineffective for post‑viral UACS. [3]

Indications and Regimen for Antibiotic Therapy

  • Antibiotics are indicated when all of the following are present: symptoms > 10 days without improvement, purulent nasal discharge, and facial pain/pressure. 1
  • First‑line agent: Amoxicillin‑clavulanate, covering Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 4
  • Duration: 5–10 days, based on clinical guidelines for acute bacterial sinusitis. 4

Diagnostic Work‑up When Initial Therapy Fails

  • If no clinical improvement after 2 weeks of appropriate therapy, obtain a chest radiograph to rule out pneumonia or other pulmonary pathology. 5
  • Perform spirometry to exclude underlying asthma or COPD, especially in patients with recurrent morning cough. 5
  • Consider ENT referral for nasal endoscopy when structural abnormalities (e.g., deviated septum, polyps) are suspected. 2

Red‑Flag Signs Requiring Immediate Re‑assessment

  • Development of periorbital edema or erythema suggests possible orbital complications of sinusitis and warrants urgent evaluation. 1

Common Pitfalls to Avoid

  • Do not assume the presentation is simple allergic rhinitis; the evolution to purulent discharge and absence of classic allergic symptoms argue against it. 2
  • Do not overlook underlying asthma; persistent cough despite UACS treatment should prompt bronchodilator trial and spirometric assessment. 5

Acute Viral Rhinosinusitis Diagnosis and Management

Diagnostic Criteria

  • The American Academy of Allergy, Asthma, and Immunology recommends that symptoms present for only 3 days, with no "double sickening" pattern, are consistent with viral rhinosinusitis 6, 7
  • The presence of green mucous discharge alone is insufficient for bacterial diagnosis, as it represents white blood cells and desquamated epithelium from normal viral inflammatory response 8
  • Bilateral temporal headache with pressure-like quality is consistent with viral URI 6, 8

Treatment Guidelines

  • The American College of Physicians recommends symptomatic management for viral rhinosinusitis, including ibuprofen 400-600mg every 6-8 hours as needed for pain/headache, and first-generation antihistamine combined with oral decongestant every 4-6 hours for congestion 8
  • Saline nasal irrigation 2-3 times daily is recommended, as it has no rebound effect, unlike topical decongestants 8
  • If using topical decongestant, limit to 3-5 days maximum to avoid rebound congestion 8

Infection Prevention and Management

  • The Centers for Disease Control and Prevention recommends inspecting the entire tattoo site for signs of cellulitis, abscess, or necrotizing infection, and treating as bacterial cellulitis/abscess with appropriate antibiotics if any signs of skin infection are present 6, 7
  • If systemic signs worsen or patient appears toxic, consider blood cultures and broader infectious workup 7

Follow-Up and Return Precautions

  • The American Academy of Family Physicians recommends instructing patients to return immediately if symptoms persist >10 days without improvement, worsen after initial improvement, or develop high fever >39°C with severe unilateral facial pain 6, 7, 9
  • Patients should also return if they experience severe headache with neck stiffness, vision changes, or mental status changes, or if they develop worsening tachycardia, hypotension, or signs of sepsis 6, 9

Post‑Infectious Upper Airway Cough Syndrome as the Leading Cause of Chronic Cough

Epidemiology and Triggers

  • Upper airway cough syndrome (formerly post‑nasal drip syndrome) is the most common cause of chronic cough in adults, and a recent viral upper‑respiratory infection is a well‑recognized trigger for its development 10 .